EU Clinical Trial 2018-004179-11

Effectiveness of Somatostatin Analogues in Patients with hereditary hemorrhagic telangiectasia and symptomatic gastrointestinal bleeding, the SAIPAN-trial: a multicenter, randomized, open-label, parallelgroup, superiority trial.  Jun 3, 2019

Main objective of the trial: To investigate the effectiveness of somatostatin analogues in decreasing the transfusion requirements in patients with HHT and GI bleeding who are refractory to endoscopic therapy.

Parties

Sponsors
Countries
NL
Keywords
OCTREOTIDE Octreotide

JSON preview

Similar records

Title

Source:  EMA Last updated:  Jun 5, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.